Document:

Exhibit 10.34

 

JOINDER AGREEMENT

 

This
JOINDER AGREEMENT (this “Agreement”), dated as of this 25th day of May,
2010, is entered into by and among Tornier B.V., a private company with limited
liability (besloten vennootschap met beperkte
aansprakelijkheid) organized under the laws of the Netherlands, with
corporate seat in Amsterdam (the “Company”) and Medtronic Bakken
Research Center B.V. (the “Stockholder”).

 

WHEREAS,
the Stockholder received shares of common stock of the Company (the “Stock”)
pursuant to that certain Deed of Issue, dated as of May 25, 2010 by and
between the Stockholder and the Company (the “Deed of Issue”); and

 

WHEREAS,
as a condition to the execution of the Deed of Issue and the consummation of
the transactions contemplated thereby, including the issuance of the Stock, the
Stockholder agreed to enter into and be bound by the terms and conditions of
this Agreement.

 

NOW,
THEREFORE, in consideration of the mutual covenants and agreements herein
contained, the parties hereto agree as follows:

 

1.             Joinder to Securityholders’ Agreement.  The Stockholder agrees to observe and to be
bound by all the terms and conditions of that certain Securityholders’
Agreement, dated as of July 18, 2006, by and among the Investors (as
defined therein) and the Company (the “Securityholders’ Agreement”) to
the intent and effect that the Stockholder shall (with effect from the date on
which the Stock was issued to the Stockholder) be deemed to be a party to the
Securityholders’ Agreement, with the benefit of, but subject to, all the terms
and conditions thereof.  The Stockholder
further agrees and acknowledges that it will be deemed to be a “Co-Investor”
and the Stock shall be deemed to be “Securities” for the purposes of the
Securityholders’ Agreement.  For the purpose
of delivery of notices under the Securityholders’ Agreement and for service of
process, the address of the Stockholder is set forth beneath the Stockholder’s
signature to this Agreement.  Except as
expressly modified by this Agreement, all of the terms, covenants, agreements,
conditions and other provisions of the Securityholders’ Agreement shall remain
in full force and effect in accordance with its terms.

 

2.             “Market Stand-off”.  The Stockholder agrees, if requested by the
Company and an underwriter of equity securities of the Company, not to lend,
offer, pledge, sell, contract to sell, grant any option, right or warrant to
purchase, or otherwise transfer or dispose of, directly or indirectly, any of
the Stock, or enter into any swap or other arrangement that transfers to
another, in whole or in part, any of the economic consequences of ownership of
the Stock, during the 180-day period following the effective date of a
registration statement of the Company filed under the Securities Act of 1933,
as amended, or the securities laws of any non-U.S. jurisdiction.  If requested by the underwriters, the
Stockholder shall execute a separate agreement to the foregoing effect.  The Company may impose stop-transfer
instructions with respect to the Stock subject to the foregoing restrictions
until the end of said 180-day period. 
The provisions of this Section 2 shall be binding upon any
transferee who acquires any of the Stock and concurrently with any transfer of
Stock, the transferee shall agree in writing to be bound by the terms and
conditions of this Section 2.

 

1

 

3.             Governing Law and Jurisdiction.  Except for Section 2, which shall be
governed by the laws of the State of New York, this Agreement and the rights
and obligations of the parties hereunder and the persons subject hereto shall
be governed by, and construed and interpreted in accordance with, the laws of
the Netherlands, without giving effect to the choice of law principles thereof.

 

* * *

 

[Remainder of Page Intentionally Left Blank]

 

2

 

IN
WITNESS WHEREOF, the undersigned has executed this Joinder Agreement as of the
date first above written.

 

	
   

  	
  COMPANY:

  
	
   

  	
   

  
	
   

  	
  TORNIER
  B.V.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  	
  /s/  Guido
  F.X.M. Nieuwenhuizen

  
	
   

  	
  By:

  	
  Guido
  F.X.M. Nieuwenhuizen

  
	
   

  	
  Its:

  	
  Managing
  Director A

  
	
   

  	
   

  
	
   

  	
   

  	
  /s/  Ronald
  Arendsen

  
	
   

  	
  By:

  	
  Ronald
  Arendsen

  
	
   

  	
  Its:

  	
  Managing
  Director B

  
	
   

  	
   

  
	
   

  	
  STOCKHOLDER:

  
	
   

  	
   

  
	
   

  	
  MEDTRONIC
  BAKKEN RESEARCH CENTER B.V.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  	
  /s/  F.W.
  Lindemans

  
	
   

  	
  By:

  	
  Mr. F.W.
  Lindemans

  
	
   

  	
  Its:

  	
  Managing
  Director

  
	
   

  	
   

  
	
   

  	
  Address:

  
	
   

  	
  (please print)

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Facsimile:

  

 

[Signature Page to Joinder to Securityholders’ Agreement -
Medtronic]

 

3Exhibit 10.35

 

QUALITY ASSURANCE AGREEMENT

 

entered
into between

 

CeramTec
AG, Innovative Ceramic Engineering,

Fabrikstrasse 23-29

73207 Plochingen

Germany

 

-
hereinafter referred to as “CeramTec” -

 

and

 

Tornier
SA

Chemin Doyen Gosse

F-38330 St. Ismier

France

 

-
hereinafter referred to as “TORNIER” -

 

Preamble

 

WHEREAS,
CERAMTEC owns proprietary technology regarding the reliable connection between
the ceramic Ball Head and the metal stem of an artificial hip joint prosthesis
which was developed from various CERAMTEC-patents.  In addition, CERAMTEC is the manufacturer of
BIOLOX, BIOLOX forte and ZIOLOX forte ceramic Ball Heads and BIOLOX Wear
Couples (hereinafter referred to as “CERAMIC PRODUCTS”).

 

WHEREAS,
TORNIER is engaged in the field of developing, manufacturing, and marketing of
artificial hip joint prostheses.  TORNIER
declares that it manufactures these hip joint prostheses according to the
respective state of technology.  For over
10 years, TORNIER has already been selling hip prostheses with zirconium heads.

 

WHEREAS,
the parties desire to enter into a business relation, in which CERAMTEC
supplies TORNIER with CERAMIC PRODUCTS for the use with hip joint prostheses
manufactured by TORNIER.

 

WHEREAS,
the parties intend to make all efforts to achieve a maximum of product safety
of said hip joint prostheses.

 

NOW
THEREFORE, the parties agree to as follows:

 

Article 1

Documentation of quality requirements

 

(1)           CERAMTEC will make available to TORNIER
confidential information regarding the reliable connection between a CERAMIC
HEAD and the metal stem of a hip joint 

 

1

 

prosthesis
in order to enable TORNIER to manufacture metal stems having proper designs and
dimensions.  These information include:

 

a)                                      confidential drawings of the CERAMTEC taper designs,

 

b)                                     confidential drawings of the CERAMIC PRODUCTS (either BIOLOX, BIOLOX
forte or ZIOLOX forte as agreed),

 

c)                                      confidential proprietary technology concerning methods for the
measurement of the critical taper dimensions such as angle, roughness,
straightness, and roundness of the tapers as described in the CERAMTEC
instruction “Q.A. - Testing Procedures”.

 

-
hereinafter referred to as “DOCUMENTS” -

 

(2)           CERAMTEC shall make available the DOCUMENTS to
TORNIER after receipt of duly signed copies of this agreement and of the “SECRECY
AGREEMENT” attached hereto as (Annex 1).

 

(3)           During the term of this agreement TORNIER is
authorised to make full and royalty free use of DOCUMENTS for the purposes
stated in this agreement.

 

Article 2

Measures of continuing quality assurance

 

(1)           Prior to the beginning of the supply with CERAMIC
PRODUCTS TORNIER shall submit to CERAMTEC the first ten stems of each type of
hip joint prosthesis to be used with CERAMIC PRODUCTS in order to enable
CERAMTEC the verification of the compliance of the taper of the stem with the
requirements and specifications as contained in the DOCUMENTS.

 

If
CERAMTEC ascertains the compliance of these tapers with the requirements and
specifications it will execute TORNIER orders for CERAMIC PRODUCTS (either
BIOLOX or ZIOLOX as agreed).

 

(2)           Additionally CERAMTEC will on occasion monitor the
compliance of the tapers with the requirements and specifications by requesting
and evaluating samples.  After conclusion
of these examinations the samples will be returned to TORNIER undamaged.

 

(3)           TORNIER agrees to inform CERAMTEC of its intention
to introduce additional types of hip stems that will use CERAMIC PRODUCTS.  The use of CERAMIC PRODUCTS with these new
stems shall require TORNIER to follow the procedure outlined in subsection (1) and
(2) above.

 

2

 

Article 3

Instruction or customers; reports

 

(1)           TORNIER undertakes to instruct its customers in the
proper use of CERAMIC PRODUCTS before or during implantation.

 

(2)           In addition, TORNIER shall inform CERAMTEC of any
incident or event caused by or in connection with the use of CERAMIC PRODUCTS.

 

Article 4

Guarantee of maximum product safety

 

To
guarantee a maximum of product safety and to avoid product liability claims of
third parties TORNIER agrees to use CERAMIC PRODUCTS only in connection with
those types of prostheses which meet the quality requirements as described in
the DOCUMENTS and which are approved by CERAMTEC for such use, and to purchase
alumine-alumine hip articulations solely from CERAMTEC.

 

Article 5

Meeting of laws and government regulations; obtaining of approvals

 

TORNIER
shall be responsible for meeting all applicable laws and government regulations
regarding to and shall obtain all approvals necessary for manufacturing and
marketing of artificial hip joint prostheses with CERAMIC PRODUCTS.  CERAMTEC agrees to supply to TORNIER such
technical information as it is necessary to obtain such approval, to the extent
that CERAMTEC is able to do so.

 

Article 6

Product liability

 

(1)           Each party shall be responsible for its own product
liability as stated in the applicable product liability acts or any other laws
regulating product liability.

 

(2)           Quality examinations and monitoring of tapers as
agreed in Article 2 subsections (1) and (2) above shall not
release TORNIER of any of its obligations regarding product safety and product
liability.

 

Article 7

Term and termination

 

(1)           This agreement has been made in writing and shall
become effective after execution by each of the parties.  The term of this Agreement shall be for two (2) years
and shall renew automatically on a yearly basis thereafter, unless terminated
by either party six (6) months prior to the end of the two (2) year
period or any subsequent contract year. 
The notice of termination must be per registered mail.  The date of the post stamp decides whether
the notice arrived in time.

 

3

 

Each
parties’ right to terminate this agreement for important reason without notice
shall be unaffected.  Important reason
shall mean any material breach of the obligations under this agreement
including an infringement of the SECRECY AGREEMENT (Annex 1).

 

(2)           After ending of this agreement TORNIER is not
longer authorised to make use of the DOCUMENTS and the information contained
herein and shall return all DOCUMENTS to CERAMTEC without delay.

 

Article 8

Other Products

 

The
parties agree to handle the supply of other CERAMTEC products, TORNIER desires
to be delivered with in future, under the terms of this Agreement as well.  In particular, these products shall follow a
quality-assurance procedure according to Article 2.  Details shall be mutually agreed upon by the
parties in annexes to this Agreement.

 

Article 9

Miscellaneous

 

(1)           If any provisions of this Agreement are legally
invalid or unperformable either in part or in their entirety, or later become
legally invalid or unperformable, the legal validity of the remaining terms of
the Agreement shall remain unaffected. 
In such a case, each party has the right to demand that a legally valid,
performable provision shall be agreed upon that best suits the purposes pursued
with the invalid or unperformable provision.

 

(2)           In the event of any dispute between the parties
relative to this agreement, or any transactions concluded hereunder, the
parties shall attempt to arrive a settlement acceptable to both parties.  If, however, a settlement cannot be reached,
the parties agree that any legal action based upon such a dispute or any claims
arising out of this agreement shall be exclusively brought before and decided
by the courts competent for the principal place of the defending party in
application of the laws of such place of jurisdiction.

 

	
  Plochingen,
  31.3.1998

  	
   

  	
  Montbonnot,
  01.04.1998

  
	
  CeramTec
  AG

  	
   

  	
  TORNIER

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  by:

  	
  /s/
  Dr. Manek Buttermilch

  	
   

  	
  by:

  	
  /s/
  Alain Tornier

  
					

 

4

 

 

SECRECY AGREEMENT

 

between

 

CeramTec
AG, Innovative Ceramic Engineering,

Fabrikstrasse
23-29

73207 Plochingen

Germany

 

-
hereinafter referred to as “CERAMTEC” -

 

and

 

Tornier
SA

Chemin Doyen Gosse

F-38330 St. Ismier

France

 

-
hereinafter referred to as “TORNIER” -

 

Preamble

 

CERAMTEC
and TORNIER desire to enter into a business relation as described in the
QUALITY ASSURANCE AGREEMENT.

 

Within
the scope of said cooperation it may be necessary for CERAMTEC or TORNIER to
disclose to each other confidential technical or business information,
specifications, drawings, samples, models, intentions, experiences, and
Know-how.  In addition, CERAMTEC will
submit to TORNIER DOCUMENTS according to Art. 1 of said QUALITY ASSURANCE AGREEMENT.

 

-
hereinafter referred to as “INFORMATION” -

 

Now,
therefore, the parties agree to as follows:

 

1.                                       Each of the parties agrees to keep all INFORMATION strictly confidential,
not to disclose it to any third party without the prior written consent of the
other party and to make use of it only for the purposes stated in the QUALITY
ASSURANCE AGREEMENT.

 

2.                                       The foregoing obligations do not apply to INFORMATION which

 

a)                                      is already known to the receiving party or in
the public domain at the time of the disclosure;

 

b)                                     becomes publicly known without a breach of the
receiving party’s obligations under this Secrecy Agreement;

 

c)                                      is independently developed by the receiving
party at the time of the disclosure;

 

 

d)                                     is disclosed after the receiving party gave
notice in writing to the disclosing party not to leave any further INFORMATION;

 

e)                                      is approved for release by written
authorization of the disclosing party.

 

The
burden of proof of the foregoing exceptions rests on the receiving party.

 

Any
publication or disclosure of INFORMATION to a third party referring to the
foregoing exceptions requires the prior written consent of the disclosing
party.  The consent has to be granted,
when such an exception has been met.

 

3.                                       Each party agrees that it shall disclose INFORMATION only to those of its
employees, who have first agreed in written to be bound by the terms of this
Secrecy Agreement.  Any other persons,
including the affiliated companies of the parties, shall be regarded as third
parties.

 

4.                                       As far as the receiving party has been authorized by the disclosing party
to submit INFORMATION to a third party, the disclosure shall be made only after
the third party has agreed in writing to be bound by the terms of this
Agreement.

 

5.                                       Any property rights concerning INFORMATION shall remain to the disclosing
party.

 

6.                                       After the ending of the QUALITY ASSURANCE AGREEMENT the receiving party
shall immediately return to the disclosing party all documents and other
material in its possession, including all copies, incorporating the disclosing
party’s INFORMATION.

 

7.                                       This Agreement comes into effect after execution by either party.  The obligations of confidentiality set forth
in this Agreement shall expire after a period of ten (10) years after the
ending of the QUALITY ASSURANCE AGREEMENT.

 

8.                                       This Agreement shall be binding upon the legal successors of the parties.

 

	
  Plochingen,
  03.02.1998

  	
   

  	
  Montbonnot,
  01.04.1998

  
	
  CeramTec
  AG

  	
   

  	
  TORNIER

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  by:

  	
  /s/
  Dr. Manek Buttermilch

  	
   

  	
  by:

  	
  /s/
  Alain Tornier

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00178-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00178-of-00352.parquet"}]]